Drug Profile
NM 0134
Alternative Names: NM-0134Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Nanomerics
- Class Eye disorder therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Eye disorders
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Eye-disorders in United Kingdom
- 28 Jul 2016 Preclinical trials in Eye disorders in United Kingdom (unspecified route)